A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues-Reference-Cited by-同舟云学术

A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues

Published:2022-10 Issue: Volume:Volume 17 Page:4895-4910
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Liu Jiaojiao,Zhang Naining,Wu Jiaan,Dong Peng,Lv Hongshuai,Wang Qi,Wang Shenxu,Yang Haotong,Wang Si,Li Xiaohai,Hu Jinghua,Wang Anny,Li Daisy J,Shi Yikang^ORCID

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Reference53 articles.

1. Carbohydrate-based amphiphilic nano delivery systems for cancer therapy

2. Positron Emission Tomography (PET) Imaging with [11C]-Labeled Erlotinib: A Micro-PET Study on Mice with Lung Tumor Xenografts

3. 68 Ga labeled Erlotinib: A novel PET probe for imaging EGFR over-expressing tumors

4. Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors

5. Molecular imaging of gefitinib activity in an epidermal growth factor receptor (EGFR)-bearing xenograft model

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of polysaccharides in enzyme-triggered oral colon-specific drug delivery systems: A review;International Journal of Biological Macromolecules;2024-08

2. Effect of Polymer and Cell Membrane Coatings on Theranostic Applications of Nanoparticles: A Review;Advanced Healthcare Materials;2024-06-25

3. Influence of unsaturated fatty acids on the antitumor activity of polymeric conjugates grafted with cabazitaxel against prostate cancer;Biomedicine & Pharmacotherapy;2023-12

4. Organoids technology for advancing the clinical translation of cancer nanomedicine;WIREs Nanomedicine and Nanobiotechnology;2023-04-23

5. A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy;Pharmaceutics;2023-03-11